For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the arrival of Vyndamax and Attruby represents a true breakthrough . These novel therapies preserve the https://pbm760674.mybjjblog.com/major-attr-cm-development-vyndamax-and-attruby-offer-hope-54313354